Measuring and Analyzing Length of Stay in Critical Care Trials
Harhay, Michael O, Ratcliffe, Sarah J, Small, Dylan S, Suttner, Leah H, Crowther, Michael J, Halpern, Scott D
Published in Medical care (01.09.2019)
Published in Medical care (01.09.2019)
Get more information
Journal Article
Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors
Stathis, Anastasios, Tolcher, Anthony W., Wang, Judy S., Renouf, Daniel J., Chen, Lin-Chi, Suttner, Leah H., Freshwater, Tomoko, Webber, Andrea L., Nayak, Tapan, Siu, Lillian L.
Published in Investigational new drugs (01.06.2023)
Published in Investigational new drugs (01.06.2023)
Get full text
Journal Article
Testing patient-informed approaches for visually depicting the hemoglobin A1c value to patients with poorly controlled diabetes: a randomized, controlled trial
Gopalan, Anjali, Suttner, Leah, Troxel, Andrea B, McDonough, Kevin, Schapira, Marilyn M
Published in BMC health services research (06.03.2020)
Published in BMC health services research (06.03.2020)
Get full text
Journal Article
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146
Makker, Vicky, Taylor, Matthew H, Aghajanian, Carol, Cohn, Allen L, Brose, Marcia S, Simone, Christopher Di, Cao, Zhu Alexander, Suttner, Leah, Loboda, Andrey, Cristescu, Razvan, Jelinic, Petar, Orlowski, Robert, Dutta, Lea, Matsui, Junji, Dutcus, Corina E, Minoshima, Yukinori, Messing, Mark J
Published in Journal for immunotherapy of cancer (19.01.2024)
Published in Journal for immunotherapy of cancer (19.01.2024)
Get full text
Journal Article
Statistical estimation of white matter microstructure from conventional MRI
Suttner, Leah H, Mejia, Amanda, Dewey, Blake, Sati, Pascal, Reich, Daniel S, Shinohara, Russell T
Published in NeuroImage clinical (01.01.2016)
Published in NeuroImage clinical (01.01.2016)
Get full text
Journal Article
A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer
Girda, Eugenia, Makker, Vicky, Marth, Christian, Van Gorp, Toon, Mirza, Mansoor, Shapira-Frommer, Ronnie, Suttner, Leah, Groisberg, Roman, Jin, Fan, O’Malley, David
Published in Gynecologic oncology (01.11.2024)
Published in Gynecologic oncology (01.11.2024)
Get full text
Journal Article
First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors
Siu, Lillian L, Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K, Wilson, Douglas C, Markensohn, Julia F, Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A, Maurice-Dror, Corinne
Published in Clinical cancer research (01.01.2022)
Published in Clinical cancer research (01.01.2022)
Get full text
Journal Article
Phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced clear cell renal cell carcinoma (ccRCC)
Motzer, Robert J., Albiges, Laurence, Choueiri, Toni K., Plimack, Elizabeth R., Rini, Brian I., Suttner, Leah, Yin, Lina, Willemann-Rogerio, Jacqueline, Hammers, Hans J.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
A phase 1b/2 umbrella study of investigational immune and targeted combination therapies as first-line therapy for patients with advanced renal cell carcinoma (RCC)
Plimack, Elizabeth R., Hammers, Hans J., Choueiri, Toni K., Rini, Brian I., Motzer, Robert J., Suttner, Leah, Perini, Rodolfo F., Willemann Rogerio, Jaqueline, Albiges, Laurence
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Association between beta-catenin ( CTNNB1 ) mutations and clinical outcomes of pembrolizumab in advanced hepatocellular carcinoma (aHCC): Exploratory analyses from KEYNOTE-240
Kudo, Masatoshi, Cheng, Ann-Lii, Merle, Philippe, Ryoo, Baek-Yeol, Decaens, Thomas, Cicin, Irfan, Dajani, Olav, Al-Rajabi, Raed Moh'd Taiseer, Peron, Jean-Marie, Chan, Stephen Lam, Knox, Jennifer J., Daniele, Bruno, Suttner, Leah, Webber, Andrea L, Pena, Carol Elaine, Cristescu, Razvan, Chen, Cai, Hatogai, Ken, Siegel, Abby B., Finn, Richard S.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer
Bessudo, Alberto, Haseeb, Abdul Mustajeeb, Reeves, James A., Zhu, Xiaofu, Wong, Lucas, Giranda, Vincent, Suttner, Leah, Liu, Fang, Chatterjee, Manash, Sharma, Sunil
Published in Clinical colorectal cancer (01.09.2024)
Published in Clinical colorectal cancer (01.09.2024)
Get full text
Journal Article
Phase 1 first-in-human study of anti–ILT3 mAb MK-0482 as monotherapy and in combination with pembrolizumab in advanced solid tumors: Dose escalation results
Gutierrez, Martin, Spreafico, Anna, Wang, Ding, Golan, Talia, Renouf, Daniel, Voskoboynik, Mark, Chatterjee, Manash Shankar, Kapadia, Kishan J., Liu, Qi, Kovvali, Gopala, Suttner, Leah, Pang, Ling, Chen, Mei, Tolcher, Anthony W.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
308 A randomized, double-blind, phase 2 study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib vs pembrolizumab plus lenvatinib in patients with previously treated mismatch repair-proficient advanced endometrial cancer
Gorp, Toon Van, Makker, Vicky, Marth, Christian, Girda, Eugenia, Mirza, Mansoor Raza, Frommer, Ronnie Shapira, Suttner, Leah, Groisberg, Roman, Jin, Fan, O’Malley, David M
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
Independent drug action and its statistical implications for development of combination therapies
Chen, Cong, Liu, Fang, Ren, Yixin, Suttner, Leah, Sun, Zhiping, Shentu, Yue, Schmidt, Emmett V.
Published in Contemporary clinical trials (01.11.2020)
Published in Contemporary clinical trials (01.11.2020)
Get full text
Journal Article
Correction: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors
Siu, Lillian L, Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K, Wilson, Douglas C, Markensohn, Julia F, Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A, Maurice-Dror, Corinne
Published in Clinical cancer research (15.09.2022)
Published in Clinical cancer research (15.09.2022)
Get full text
Journal Article
Correction: First-in-Class Anti-Immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors
Siu, Lillian L, Wang, Ding, Hilton, John, Geva, Ravit, Rasco, Drew, Perets, Ruth, Abraham, Anson K, Wilson, Douglas C, Markensohn, Julia F, Lunceford, Jared, Suttner, Leah, Siddiqi, Shabana, Altura, Rachel A, Maurice-Dror, Corinne
Published in Clinical cancer research (14.04.2022)
Published in Clinical cancer research (14.04.2022)
Get full text
Journal Article
Association between biomarkers and clinical outcomes of lenvatinib + pembrolizumab in advanced renal cell carcinoma (RCC): Results from Study 111/KEYNOTE-146
Lee, Chung-Han, Rasco, Drew W., Rao, Arpit, Taylor, Matthew H., Hsieh, James J, Pinto, Alvaro, Vogelzang, Nicholas J., Cao, Z. Alexander, Suttner, Leah, Loboda, Andrey, Vajdi, Amir, Predoiu, Raluca Andreia, Nebozhyn, Michael, Lunceford, Jared, Perini, Rodolfo F., Matsui, Junji, Minoshima, Yukinori, Dutcus, Corina E., Dutta, Lea, Motzer, Robert J.
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals
Gabler, Nicole B, Duan, Naihua, Raneses, Eli, Suttner, Leah, Ciarametaro, Michael, Cooney, Elizabeth, Dubois, Robert W, Halpern, Scott D, Kravitz, Richard L
Published in Current controlled trials in cardiovascular medicine (16.07.2016)
Published in Current controlled trials in cardiovascular medicine (16.07.2016)
Get full text
Journal Article
Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC)
Antonarakis, Emmanuel S., Piulats Rodriguez, Jose Maria M., Gross-Goupil, Marine, Goh, Jeffrey C., Vaishampayan, Ulka N., De Wit, Ronald, Alanko, Tuomo, Fukasawa, Satoshi, Tabata, Kenichi, Feyerabend, Susan, Berger, Raanan, Wu, Haiyan, Kim, Jeri, Schloss, Charles, Qiu, Ping, Suttner, Leah, Cristescu, Razvan, Marton, Matthew John, De Bono, Johann S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article